Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
about
CIViC databaseUnexpected maspin immunoreactivity in Merkel cell carcinomaQuality Indicators Associated With the Level of NCQA Accreditation.Merkel Cell Carcinoma Therapeutic Update.[Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].
P2860
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@ast
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@en
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.
@nl
type
label
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@ast
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@en
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.
@nl
altLabel
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@en
prefLabel
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@ast
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@en
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.
@nl
P2093
P2860
P356
P1476
Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
@en
P2093
Fade Mahmoud
Mallory B Shiver
P2860
P304
P356
10.1056/NEJMC1507446
P407
P577
2015-10-15T00:00:00Z